Cited by 290Nutrition and Health in AgingMuscle Physiology and DisordersFrailty in Older Adults

New horizons in the pathogenesis, diagnosis and management of sarcopenia

Open access
Sayer, A. A., Robinson, S. M., Patel, H. P., Shavlakadze, T., Cooper, C., Grounds, M. D.·2013·Age and Ageing

Abstract

Sarcopenia is the age-related loss of skeletal muscle mass and function. It is now recognised as a major clinical problem for older people and research in the area is expanding exponentially. One of the most important recent developments has been convergence in the operational definition of sarcopenia combining measures of muscle mass and strength or physical performance. This has been accompanied by considerable progress in understanding of pathogenesis from animal models of sarcopenia. Well-described risk factors include age, gender and levels of physical activity and this knowledge is now being translated into effective management strategies including resistance exercise with recent interest in the additional role of nutritional intervention. Sarcopenia is currently a major focus for drug discovery and development although there remains debate about the best primary outcome measure for trials, and various promising avenues to date have proved unsatisfactory. The concept of 'new tricks for old drugs' is, however, promising, for example, there is some evidence that the angiotensin-converting enzyme inhibitors may improve physical performance. Future directions will include a deeper understanding of the molecular and cellular mechanisms of sarcopenia and the application of a lifecourse approach to understanding aetiology as well as to informing the optimal timing of interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ageing/afs191

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The best types of exercise for sarcopenia have not been established because the effect sizes of different exercise types on patient-important outcomes are unclear.

    “However, exercise programmes for sarcopenia vary widely in type (resistance, aerobic, balance training or multicomponent, etc.), and the best types of exercise for this population have not been established because the effect sizes of different exercise types on patient‐important outcomes are unclear. 21”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Sayer AA. Sarcopenia. BMJ 2010; 341: c4097.

Cited by

Sorted by citations

Authors
Sayer, A. A., Robinson, S. M., Patel, H. P., Shavlakadze, T., Cooper, C., & Grounds, M. D.
Affiliations
  • MRC Lifecourse Epidemiology Unit (GB)
  • The University of Western Australia (AU)
Corresponding author
Sayer, A. A.
Venue
Age and Ageing
Published
2013-01-11
Volume
42
Issue
2
Pages
145-150
ISSN
  • 0002-0729 (ISSN-L)
  • 1468-2834
OpenAlex
W2137000539
Cited by
290
References
52
Citations by year
2026: 10 · 2025: 18 · 2024: 11 · 2023: 15 · 2022: 19 · 2021: 28 · 2020: 19 · 2019: 20 · 2018: 20 · 2017: 24 · 2016: 30 · 2015: 31 · 2014: 34 · 2013: 9 · 2012: 1
FWCI
3.75
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Age and Ageing (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • National Institute for Health and Care Research (ACF-2008-26-006, NF-SI-0508-10082)
  • Versus Arthritis (17413, 13181, 13157, 13147, 16349, 17702, 17265, 16095, 13230, 13085)
  • Medical Research Council (MC_UU_12011/2, MC_UU_12011/1)
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Keywords
sarcopenia, skeletal muscle atrophy, muscle strength, physical performance, risk factors, resistance training, dietary intervention, drug development, ACE inhibitors, older adults, intervention timing
MeSH terms
Age Factors, Aging, Animals, Diet, Humans, Nutritional Status, Organ Size, Prognosis, Risk Factors, Exercise, Muscle, Skeletal, Risk Reduction Behavior, Muscle Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review